Providing Effective Information to Consumers about Prescription Drug Risks and Benefits; Public Workshop

The Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER), in collaboration with FDA’s Office of the Commissioner (OC), is holding a public workshop on September 24 and 25, 2009 entitled ‘‘Providing Effective Information to Consumers About Prescription Drug Risks and Benefits.’’ This public workshop is intended to explore potential approaches that will result in written prescription drug information for consumers that is comprehensible, accurate, and easy to access.

• Federal Register Notice (PDF - 52KB)
• Final Workshop Agenda (PDF - 34KB)
• Attendee List (PDF - 30KB)
• Breakout Session Questions (PDF - 25KB)
• Prototype 1 for Rheutopia (PDF - 75KB)
• Prototype 2 for Rheutopia (PDF - 34KB)
• Prototype 3 for Rheutopia (PDF - 40KB)
• Prototype 4 for Rheutopia (PDF - 44KB)
• Providing Effective Information for Consumers about Prescription Drug Risks and Benefits: The Issues Paper (PDF - 154KB)
• Providing Effective Information to Consumers About Prescription Drug Risks and Benefits: Format and Content (PDF - 26KB)
• Improving Access and Distribution: Questions (PDF - 24KB)
• Introduction - Deborah Henderson (PDF - 68KB)
• Prototype Development - Janet Norden (PDF - 69KB)
• Workshop Summary (PDF - 24KB)
• Transcript, September 24, 2009 (PDF - 143KB)
• Transcript, September 25, 2009 (PDF - 669KB)

This workshop is now full. We won't be able to accept any more names on the wait list.